Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies

Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna-Lena Mueller, Zahra Payandeh, Niloufar Mohammadkhani, Shaden M. H. Mubarak, Alireza Zakeri, Armina Alagheband Bahrami, Aranka Brockmueller, Mehdi Shakibaei
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2d9e543844bd4114a11a1986f1c6d465
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2d9e543844bd4114a11a1986f1c6d465
record_format dspace
spelling oai:doaj.org-article:2d9e543844bd4114a11a1986f1c6d4652021-11-25T17:10:27ZRecent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies10.3390/cells101130172073-4409https://doaj.org/article/2d9e543844bd4114a11a1986f1c6d4652021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3017https://doaj.org/toc/2073-4409Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, leading to local inflammation, cartilage destruction, and bone erosion. To prevent joint damage and physical disability as one of many symptoms of RA, early diagnosis is critical. Auto-antibodies play a pivotal clinical role in patients with systemic RA. As biomarkers, they could help to make a more efficient diagnosis, prognosis, and treatment decision. Besides auto-antibodies, several other factors are involved in the progression of RA, such as epigenetic alterations, post-translational modifications, glycosylation, autophagy, and T-cells. Understanding the interplay between these factors would contribute to a deeper insight into the causes, mechanisms, progression, and treatment of the disease. In this review, the latest RA research findings are discussed to better understand the pathogenesis, and finally, treatment strategies for RA therapy are presented, including both conventional approaches and new methods that have been developed in recent years or are currently under investigation.Anna-Lena MuellerZahra PayandehNiloufar MohammadkhaniShaden M. H. MubarakAlireza ZakeriArmina Alagheband BahramiAranka BrockmuellerMehdi ShakibaeiMDPI AGarticlerheumatoid arthritisinflammationauto-antibodiesautophagyepigeneticcitrullinationBiology (General)QH301-705.5ENCells, Vol 10, Iss 3017, p 3017 (2021)
institution DOAJ
collection DOAJ
language EN
topic rheumatoid arthritis
inflammation
auto-antibodies
autophagy
epigenetic
citrullination
Biology (General)
QH301-705.5
spellingShingle rheumatoid arthritis
inflammation
auto-antibodies
autophagy
epigenetic
citrullination
Biology (General)
QH301-705.5
Anna-Lena Mueller
Zahra Payandeh
Niloufar Mohammadkhani
Shaden M. H. Mubarak
Alireza Zakeri
Armina Alagheband Bahrami
Aranka Brockmueller
Mehdi Shakibaei
Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
description Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, leading to local inflammation, cartilage destruction, and bone erosion. To prevent joint damage and physical disability as one of many symptoms of RA, early diagnosis is critical. Auto-antibodies play a pivotal clinical role in patients with systemic RA. As biomarkers, they could help to make a more efficient diagnosis, prognosis, and treatment decision. Besides auto-antibodies, several other factors are involved in the progression of RA, such as epigenetic alterations, post-translational modifications, glycosylation, autophagy, and T-cells. Understanding the interplay between these factors would contribute to a deeper insight into the causes, mechanisms, progression, and treatment of the disease. In this review, the latest RA research findings are discussed to better understand the pathogenesis, and finally, treatment strategies for RA therapy are presented, including both conventional approaches and new methods that have been developed in recent years or are currently under investigation.
format article
author Anna-Lena Mueller
Zahra Payandeh
Niloufar Mohammadkhani
Shaden M. H. Mubarak
Alireza Zakeri
Armina Alagheband Bahrami
Aranka Brockmueller
Mehdi Shakibaei
author_facet Anna-Lena Mueller
Zahra Payandeh
Niloufar Mohammadkhani
Shaden M. H. Mubarak
Alireza Zakeri
Armina Alagheband Bahrami
Aranka Brockmueller
Mehdi Shakibaei
author_sort Anna-Lena Mueller
title Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
title_short Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
title_full Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
title_fullStr Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
title_full_unstemmed Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
title_sort recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2d9e543844bd4114a11a1986f1c6d465
work_keys_str_mv AT annalenamueller recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
AT zahrapayandeh recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
AT niloufarmohammadkhani recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
AT shadenmhmubarak recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
AT alirezazakeri recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
AT arminaalaghebandbahrami recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
AT arankabrockmueller recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
AT mehdishakibaei recentadvancesinunderstandingthepathogenesisofrheumatoidarthritisnewtreatmentstrategies
_version_ 1718412638298308608